Brought to you by 
Cyterix raises $9.2mm in Series A funds
08 Jul 2011
Executive Summary
Cyterix Pharmaceuticals Inc. (anticancer prodrugs) raised $9.2mm from The Column Group and SV Life Sciences in its Series A round. Representatives from both investors have taken seats on the company’s board.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement